Fig. 5From: The role of dosimetry and biological effects in metastatic castration–resistant prostate cancer (mCRPC) patients treated with 223Ra: first in human studya) Frequencies of DC; b) MN at different time points for the investigated patients and c) dicentric distribution in PBLs of patient 1: the number of cells with one or more dicentrics (out of 200 metaphases) is represented for each experimental point; a similar trend was observed in the other patientsBack to article page